Sinovac Biotech Ltd (SVA): Operating Income
-$490.13M
Year ended 2025-12-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$490.13M | n/m | 2026-06-05, From 2025-01-01 |
| 2024-12-31 | -$505.54M | n/m | 2026-06-05, From 2024-01-01 |
| 2023-12-31 | -$713.98M | n/m | 2026-06-05, From 2023-01-01 |
| 2022-12-31 | -$508.99M | n/m | 2026-04-30, From 2022-01-01 |
| 2021-12-31 | $17.62B | n/m | 2026-04-30, From 2021-01-01 |
| 2020-12-31 | $215.64M | +214.5% | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $68.56M | +51.3% | 2022-04-29, From 2019-01-01 |
| 2018-12-31 | $45.32M | -0.2% | 2021-04-22, From 2018-01-01 |
| 2017-12-31 | $45.42M | n/m | 2020-04-30, From 2017-01-01 |
| 2016-12-31 | $504.0K | -86.4% | 2019-04-29, From 2016-01-01 |
| 2015-12-31 | $3.69M | +96.0% | 2018-05-11, From 2015-01-01 |
| 2014-12-31 | $1.89M | n/c | 2017-11-22, From 2014-01-01 |
| 2013-12-31 | $9.95M | n/c | 2016-04-25, From 2013-01-01 |
| 2012-12-31 | -$21.15M | n/m | 2015-04-29, From 2012-01-01 |
| 2011-12-31 | $3.37M | n/m | 2014-04-16, From 2011-01-01 |
| 2010-12-31 | -$13.36M | n/c | 2013-05-23, From 2010-01-01 |
| 2009-12-31 | $42.15M | n/a | 2012-04-12, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$490.13M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$12.23M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$40.98M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $163.75M | -1.9% |
| MannKind Corp (MNKD) | 2025-12-31 | $38.80M | -46.5% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$229.43M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $150.14M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $24.74M | +23.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$62.82M | n/m |
Compare SVA, ARQT, ARDX, INVA side by side · Screen every company in Pharmaceutical Preparations ↗